Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized Study of Steroid Pulse Immunotherapy in Idiopathic Cerebellar Ataxia
jRCTs031200250Recruiting
- Sponsor
- Pfizer
- Start
- Aug 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of methylprednisolone in idiopathic late onset cerebellar ataxia (ILOCA) (2 arms), sponsored by Pfizer. Started Aug 2021; status: recruiting.
02
Drugs
methylprednisolone
03
Conditions
idiopathic late onset cerebellar ataxia (ILOCA)
Beyond the preview
Go deeper on jRCTs031200250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031200250.